{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:30:04Z","timestamp":1780446604569,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13181-021-00848-1","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T18:02:41Z","timestamp":1621879361000},"page":"330-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["How Can We \u201cGet the Lead Out\u201d Without Chelators?"],"prefix":"10.1007","volume":"17","author":[{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C.","family":"Routsolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Johnson-Arbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Mycyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"848_CR1","unstructured":"Recordati Rare Diseases: Important prescribing information. https:\/\/www.recordatirarediseases.com\/sites\/www.recordatirarediseases.com\/files\/inline-files\/hcp-letter-chemet.pdf. Accessed March 3, 2021."},{"key":"848_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/15563650.2015.1043441","volume":"53","author":"M Mazer-Amirshahi","year":"2015","unstructured":"Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: implications for medical toxicology. Clin Toxicol (Phila). 2015;53:519\u201324.","journal-title":"Clin Toxicol (Phila)"},{"key":"848_CR3","unstructured":"Institute for Health Metrics and Evaluation (IHME). 2017. GBD compare. Seattle, WA: IHME, University of Washington."},{"key":"848_CR4","unstructured":"World Health Organization: Lead. https:\/\/www.who.int\/ipcs\/assessment\/public_health\/lead\/en\/. Accessed March 3, 2021."},{"key":"848_CR5","unstructured":"Centers for Disease Control and Prevention. Childhood lead poisoning prevention. https:\/\/www.cdc.gov\/nceh\/lead\/default.htm. Accessed March 3, 2021."},{"key":"848_CR6","unstructured":"Centers for Disease Control and Prevention. Recommended actions based on blood lead level. https:\/\/www.cdc.gov\/nceh\/lead\/advisory\/acclpp\/actions-blls.htm. Accessed March 3, 2021."},{"key":"848_CR7","unstructured":"World Health Organization Model Lists of Essential Medications, 2019. https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists. ."},{"key":"848_CR8","unstructured":"World Health Organization. Review of succimer for the treatment of lead poisoning. https:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/succimer.pdf?ua=1. Accessed March 15, 2021."},{"key":"848_CR9","doi-asserted-by":"publisher","unstructured":"Blaurock-Busch E. DMPS in metal chelation. Biomed J Sci &Tech Res. 2020;30. https:\/\/doi.org\/10.26717\/BJSTR.2020.30.004918.","DOI":"10.26717\/BJSTR.2020.30.004918"},{"key":"848_CR10","doi-asserted-by":"crossref","unstructured":"Paeezi M, Zamani N, Hassanian-Moghaddam H, Shadnia S, Zamani N, Chaleshi V, et al. Treatment of adult lead poisoning with D-penicillamine. Drug Metab Pers Ther. 2019;34(2).","DOI":"10.1515\/dmpt-2019-0003"},{"key":"848_CR11","unstructured":"RED BOOK Online. Greenwood Village (CO): IBM Corporation. www.micromedexsolutions.com. Subscription required to view. Accessed March 25, 2021."},{"key":"848_CR12","unstructured":"Young A, Nicholas M. USA Today. Beyond flint: excessive lead levels found in almost 2000 water systems across all 50 states. https:\/\/www.usatoday.com\/story\/news\/2016\/03\/11\/nearly-2000-water-systems-fail-lead-tests\/81220466\/. Accessed April 29, 2021."},{"key":"848_CR13","first-page":"1068","volume":"78","author":"S Tong","year":"2000","unstructured":"Tong S, von Schirnding YE, Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. Bull World Health Organ. 2000;78:1068\u201377.","journal-title":"Bull World Health Organ"},{"key":"848_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/acem.12389","volume":"21","author":"M Mazer-Amirshahi","year":"2014","unstructured":"Mazer-Amirshahi M, Pourmand A, Singer S, Pines JM, van den Anker. Critical drug shortages: implications for emergency medicine. Acad Emerg Med. 2014;21:704\u201311.","journal-title":"Acad Emerg Med"},{"key":"848_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/clpt.2012.235","volume":"93","author":"SL Kweder","year":"2013","unstructured":"Kweder SL, Dill S. Drug shortages: the cycle quantity and quality. Clin Pharmacol Ther. 2013;93:245\u201351.","journal-title":"Clin Pharmacol Ther"},{"key":"848_CR16","unstructured":"FDA. Fact sheet: drug products in shortage in the United States. https:\/\/www.fda.gov\/regulatory-information\/food-and-drug-administration-safety-and-innovation-act-fdasia\/fact-sheet-drug-products-shortage-united-states. Accessed March 15, 2021."},{"key":"848_CR17","unstructured":"United States Senate. S 3548 Coronavirus Aid, Relief, and Economic Security (CARES) Act. https:\/\/www.congress.gov\/116\/bills\/s3548\/ BILLS-116s3548is.pdf. Accessed March 15,2021."},{"key":"848_CR18","first-page":"521","volume":"14","author":"E Friske","year":"2013","unstructured":"Friske E. Addressing looming prescription drug shortages through legislative and regulatory approaches. Minn J L Sci Tech. 2013;14:521\u201339.","journal-title":"Minn J L Sci Tech"},{"key":"848_CR19","unstructured":"U.S. Food and Drug Administration. Search list of extended use dates to assist with drug shortages. https:\/\/www.fda.gov\/drugs\/drug-shortages\/search-list-extended-use-dates-assist-drug-shortages. Accessed March 17, 2021."},{"key":"848_CR20","unstructured":"FDA. Consumer and Health Care Professional Information. https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/consumer-and-health-care-professional-information. Accessed March 18, 2021."},{"key":"848_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-013-0005-9","volume":"13","author":"J Gudeman","year":"2013","unstructured":"Gudeman J, Jozwiakowski M, Chollet J, et al. Potential risks of pharmacy compounding. Drugs R D. 2013;13:1\u20138.","journal-title":"Drugs R D"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-021-00848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-021-00848-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-021-00848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T18:30:15Z","timestamp":1632249015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-021-00848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1007\/s13181-021-00848-1","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Maryann Mazer-Amirshahi and Mark B. Mycyk are members of the editorial board of Journal of Medical Toxicology (JMT).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}